N-end rule and retroviral infection: no effect on integrase
BACKGROUND: Integration of double stranded viral DNA is a key step in the retroviral life cycle. Virally encoded enzyme, integrase, plays a central role in this reaction. Mature forms of integrase of several retroviruses (i.e. HIV-1 and MLV) bear conserved destabilizing N-terminal residues of the N-...
Saved in:
Published in | Virology journal Vol. 10; no. 1; p. 233 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
England
Springer-Verlag
13.07.2013
BioMed Central Ltd BioMed Central |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | BACKGROUND: Integration of double stranded viral DNA is a key step in the retroviral life cycle. Virally encoded enzyme, integrase, plays a central role in this reaction. Mature forms of integrase of several retroviruses (i.e. HIV-1 and MLV) bear conserved destabilizing N-terminal residues of the N-end rule pathway - a ubiquitin dependent proteolytic system in which the N-terminal residue of a protein determines its half life. Substrates of the N-end rule pathway are recognized by E3 ubiquitin ligases called N-recognins. We have previously shown that the inactivation of three of these N-recognins, namely UBR1, UBR2 and UBR4 in mouse embryonic fibroblasts (MEFs) leads to increased stability of ectopically expressed HIV-1 integrase. These findings have prompted us to investigate the involvement of the N-end rule pathway in the HIV-1 life cycle. RESULTS: The infectivity of HIV-1 but not MLV was decreased in N-recognin deficient cells in which three N-recognins (UBR1, UBR2 and UBR4) were depleted. HIV-1 integrase mutants of N-terminal amino acids (coding for stabilizing or destabilizing residues) were severely impaired in their infectivity in both human and mouse cells. Quantitative PCR analysis revealed that this inhibition was mainly caused by a defect in reverse transcription. The decreased infectivity was independent of the N-end rule since cells deficient in N-recognins were equally refractory to infection by the integrase mutants. MLV integrase mutants showed no difference in their infectivity or intravirion processing of integrase. CONCLUSIONS: The N-end rule pathway impacts the early phase of the HIV-1 life cycle; however this effect is not the result of the direct action of the N-end rule pathway on the viral integrase. The N-terminal amino acid residue of integrase is highly conserved and cannot be altered without causing a substantial decrease in viral infectivity. |
---|---|
AbstractList | Integration of double stranded viral DNA is a key step in the retroviral life cycle. Virally encoded enzyme, integrase, plays a central role in this reaction. Mature forms of integrase of several retroviruses (i.e. HIV-1 and MLV) bear conserved destabilizing N-terminal residues of the N-end rule pathway - a ubiquitin dependent proteolytic system in which the N-terminal residue of a protein determines its half life. Substrates of the N-end rule pathway are recognized by E3 ubiquitin ligases called N-recognins. We have previously shown that the inactivation of three of these N-recognins, namely UBR1, UBR2 and UBR4 in mouse embryonic fibroblasts (MEFs) leads to increased stability of ectopically expressed HIV-1 integrase. These findings have prompted us to investigate the involvement of the N-end rule pathway in the HIV-1 life cycle.
The infectivity of HIV-1 but not MLV was decreased in N-recognin deficient cells in which three N-recognins (UBR1, UBR2 and UBR4) were depleted. HIV-1 integrase mutants of N-terminal amino acids (coding for stabilizing or destabilizing residues) were severely impaired in their infectivity in both human and mouse cells. Quantitative PCR analysis revealed that this inhibition was mainly caused by a defect in reverse transcription. The decreased infectivity was independent of the N-end rule since cells deficient in N-recognins were equally refractory to infection by the integrase mutants. MLV integrase mutants showed no difference in their infectivity or intravirion processing of integrase.
The N-end rule pathway impacts the early phase of the HIV-1 life cycle; however this effect is not the result of the direct action of the N-end rule pathway on the viral integrase. The N-terminal amino acid residue of integrase is highly conserved and cannot be altered without causing a substantial decrease in viral infectivity. Integration of double stranded viral DNA is a key step in the retroviral life cycle. Virally encoded enzyme, integrase, plays a central role in this reaction. Mature forms of integrase of several retroviruses (i.e. HIV-1 and MLV) bear conserved destabilizing N-terminal residues of the N-end rule pathway - a ubiquitin dependent proteolytic system in which the N-terminal residue of a protein determines its half life. Substrates of the N-end rule pathway are recognized by E3 ubiquitin ligases called N-recognins. We have previously shown that the inactivation of three of these N-recognins, namely UBR1, UBR2 and UBR4 in mouse embryonic fibroblasts (MEFs) leads to increased stability of ectopically expressed HIV-1 integrase. These findings have prompted us to investigate the involvement of the N-end rule pathway in the HIV-1 life cycle. The infectivity of HIV-1 but not MLV was decreased in N-recognin deficient cells in which three N-recognins (UBR1, UBR2 and UBR4) were depleted. HIV-1 integrase mutants of N-terminal amino acids (coding for stabilizing or destabilizing residues) were severely impaired in their infectivity in both human and mouse cells. Quantitative PCR analysis revealed that this inhibition was mainly caused by a defect in reverse transcription. The decreased infectivity was independent of the N-end rule since cells deficient in N-recognins were equally refractory to infection by the integrase mutants. MLV integrase mutants showed no difference in their infectivity or intravirion processing of integrase. The N-end rule pathway impacts the early phase of the HIV-1 life cycle; however this effect is not the result of the direct action of the N-end rule pathway on the viral integrase. The N-terminal amino acid residue of integrase is highly conserved and cannot be altered without causing a substantial decrease in viral infectivity. Background: Integration of double stranded viral DNA is a key step in the retroviral life cycle. Virally encoded enzyme, integrase, plays a central role in this reaction. Mature forms of integrase of several retroviruses (i.e. HIV-1 and MLV) bear conserved destabilizing N-terminal residues of the N-end rule pathway - a ubiquitin dependent proteolytic system in which the N-terminal residue of a protein determines its half life. Substrates of the N-end rule pathway are recognized by E3 ubiquitin ligases called N-recognins. We have previously shown that the inactivation of three of these N-recognins, namely UBR1, UBR2 and UBR4 in mouse embryonic fibroblasts (MEFs) leads to increased stability of ectopically expressed HIV-1 integrase. These findings have prompted us to investigate the involvement of the N-end rule pathway in the HIV-1 life cycle. Results: The infectivity of HIV-1 but not MLV was decreased in N-recognin deficient cells in which three N-recognins (UBR1, UBR2 and UBR4) were depleted. HIV-1 integrase mutants of N-terminal amino acids (coding for stabilizing or destabilizing residues) were severely impaired in their infectivity in both human and mouse cells. Quantitative PCR analysis revealed that this inhibition was mainly caused by a defect in reverse transcription. The decreased infectivity was independent of the N-end rule since cells deficient in N-recognins were equally refractory to infection by the integrase mutants. MLV integrase mutants showed no difference in their infectivity or intravirion processing of integrase. Conclusions: The N-end rule pathway impacts the early phase of the HIV-1 life cycle; however this effect is not the result of the direct action of the N-end rule pathway on the viral integrase. The N-terminal amino acid residue of integrase is highly conserved and cannot be altered without causing a substantial decrease in viral infectivity. Background Integration of double stranded viral DNA is a key step in the retroviral life cycle. Virally encoded enzyme, integrase, plays a central role in this reaction. Mature forms of integrase of several retroviruses (i.e. HIV-1 and MLV) bear conserved destabilizing N-terminal residues of the N-end rule pathway - a ubiquitin dependent proteolytic system in which the N-terminal residue of a protein determines its half life. Substrates of the N-end rule pathway are recognized by E3 ubiquitin ligases called N-recognins. We have previously shown that the inactivation of three of these N-recognins, namely UBR1, UBR2 and UBR4 in mouse embryonic fibroblasts (MEFs) leads to increased stability of ectopically expressed HIV-1 integrase. These findings have prompted us to investigate the involvement of the N-end rule pathway in the HIV-1 life cycle. Results The infectivity of HIV-1 but not MLV was decreased in N-recognin deficient cells in which three N-recognins (UBR1, UBR2 and UBR4) were depleted. HIV-1 integrase mutants of N-terminal amino acids (coding for stabilizing or destabilizing residues) were severely impaired in their infectivity in both human and mouse cells. Quantitative PCR analysis revealed that this inhibition was mainly caused by a defect in reverse transcription. The decreased infectivity was independent of the N-end rule since cells deficient in N-recognins were equally refractory to infection by the integrase mutants. MLV integrase mutants showed no difference in their infectivity or intravirion processing of integrase. Conclusions The N-end rule pathway impacts the early phase of the HIV-1 life cycle; however this effect is not the result of the direct action of the N-end rule pathway on the viral integrase. The N-terminal amino acid residue of integrase is highly conserved and cannot be altered without causing a substantial decrease in viral infectivity. Keywords: N-end rule, HIV-1, MLV, Integrase Abstract Background Integration of double stranded viral DNA is a key step in the retroviral life cycle. Virally encoded enzyme, integrase, plays a central role in this reaction. Mature forms of integrase of several retroviruses (i.e. HIV-1 and MLV) bear conserved destabilizing N-terminal residues of the N-end rule pathway - a ubiquitin dependent proteolytic system in which the N-terminal residue of a protein determines its half life. Substrates of the N-end rule pathway are recognized by E3 ubiquitin ligases called N-recognins. We have previously shown that the inactivation of three of these N-recognins, namely UBR1, UBR2 and UBR4 in mouse embryonic fibroblasts (MEFs) leads to increased stability of ectopically expressed HIV-1 integrase. These findings have prompted us to investigate the involvement of the N-end rule pathway in the HIV-1 life cycle. Results The infectivity of HIV-1 but not MLV was decreased in N-recognin deficient cells in which three N-recognins (UBR1, UBR2 and UBR4) were depleted. HIV-1 integrase mutants of N-terminal amino acids (coding for stabilizing or destabilizing residues) were severely impaired in their infectivity in both human and mouse cells. Quantitative PCR analysis revealed that this inhibition was mainly caused by a defect in reverse transcription. The decreased infectivity was independent of the N-end rule since cells deficient in N-recognins were equally refractory to infection by the integrase mutants. MLV integrase mutants showed no difference in their infectivity or intravirion processing of integrase. Conclusions The N-end rule pathway impacts the early phase of the HIV-1 life cycle; however this effect is not the result of the direct action of the N-end rule pathway on the viral integrase. The N-terminal amino acid residue of integrase is highly conserved and cannot be altered without causing a substantial decrease in viral infectivity. Doc number: 233 Abstract Background: Integration of double stranded viral DNA is a key step in the retroviral life cycle. Virally encoded enzyme, integrase, plays a central role in this reaction. Mature forms of integrase of several retroviruses (i.e. HIV-1 and MLV) bear conserved destabilizing N-terminal residues of the N-end rule pathway - a ubiquitin dependent proteolytic system in which the N-terminal residue of a protein determines its half life. Substrates of the N-end rule pathway are recognized by E3 ubiquitin ligases called N-recognins. We have previously shown that the inactivation of three of these N-recognins, namely UBR1, UBR2 and UBR4 in mouse embryonic fibroblasts (MEFs) leads to increased stability of ectopically expressed HIV-1 integrase. These findings have prompted us to investigate the involvement of the N-end rule pathway in the HIV-1 life cycle. Results: The infectivity of HIV-1 but not MLV was decreased in N-recognin deficient cells in which three N-recognins (UBR1, UBR2 and UBR4) were depleted. HIV-1 integrase mutants of N-terminal amino acids (coding for stabilizing or destabilizing residues) were severely impaired in their infectivity in both human and mouse cells. Quantitative PCR analysis revealed that this inhibition was mainly caused by a defect in reverse transcription. The decreased infectivity was independent of the N-end rule since cells deficient in N-recognins were equally refractory to infection by the integrase mutants. MLV integrase mutants showed no difference in their infectivity or intravirion processing of integrase. Conclusions: The N-end rule pathway impacts the early phase of the HIV-1 life cycle; however this effect is not the result of the direct action of the N-end rule pathway on the viral integrase. The N-terminal amino acid residue of integrase is highly conserved and cannot be altered without causing a substantial decrease in viral infectivity. |
ArticleNumber | 233 |
Audience | Academic |
Author | Tae Kwon, Yong Somia, Nikunj V Boso, Guney Tasaki, Takafumi |
AuthorAffiliation | 2 Medical Research Institute, Kanazawa Medical University, Ishikawa, Japan 3 Center for Pharmacogenetics and Department of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, USA 5 Department of Genetics, Cell Biology and Development, University of Minnesota, 6-160 Jackson Hall, 321, Church St., SE, Minneapolis, MN 55455, USA 1 Developmental Biology and Genetics Graduate Program, Molecular, Cellular, University of Minnesota, Minneapolis, MN, USA 4 Department of Biomedical Sciences, College of Medicine, Seoul National University, Seoul 110-799, Korea |
AuthorAffiliation_xml | – name: 1 Developmental Biology and Genetics Graduate Program, Molecular, Cellular, University of Minnesota, Minneapolis, MN, USA – name: 2 Medical Research Institute, Kanazawa Medical University, Ishikawa, Japan – name: 4 Department of Biomedical Sciences, College of Medicine, Seoul National University, Seoul 110-799, Korea – name: 3 Center for Pharmacogenetics and Department of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, USA – name: 5 Department of Genetics, Cell Biology and Development, University of Minnesota, 6-160 Jackson Hall, 321, Church St., SE, Minneapolis, MN 55455, USA |
Author_xml | – sequence: 1 fullname: Boso, Guney – sequence: 2 fullname: Tasaki, Takafumi – sequence: 3 fullname: Tae Kwon, Yong – sequence: 4 fullname: Somia, Nikunj V |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/23849394$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kt1r1jAUxoNM3Ifee6UFb_SiM19NmwnCePFjMBScA-9Cmp7UjDaZSTv0vzflna-rTHKR5OR3npw8OYdozwcPCD0l-JiQRrwmNWclp_RbSXBJGXuADnahvTvrfXSY0hXGjIpaPkL7lDVcMskP0JtPJfiuiPMAhV4WMMVw46IeCuctmMkFf1L4UIBddkXwOT5BH3WCx-ih1UOCJ7fzEbp8_-7r5mN5_vnD2eb0vGwFp1PJ28piKyRvOG-tbiWRnJDaMm2pNqYxVVXVlWa11BUWIITpuhYaoq2UtmtbdoTebnWv53aEzoCfcn3qOrpRx18qaKfWJ959V324UawmQjQ0C2y2Aq0L_xFYn5gwqsU8tZinCFbZ26zy8raMGH7MkCY1umRgGLSHMCdFOJFMSIl5Rl_8g16FOfpsUqawwI2sJftL9XoAle0O-XKziKrTivHsGKvqTB3fQ-XRwehM7gfrcnyV8GqVkJkJfk69nlNSZxdf1izesiaGlCLYnSn50UuL3WfDs7u_sUv401MZeL4FrA5K99EldXlBMakwpqSpKWe_Adbc1UI |
CitedBy_id | crossref_primary_10_1126_science_aaa3844 crossref_primary_10_3390_v15122412 crossref_primary_10_1128_JVI_02312_14 crossref_primary_10_3390_v15020290 crossref_primary_10_3390_microorganisms9061219 |
Cites_doi | 10.1128/jvi.69.1.376-386.1995 10.1073/pnas.93.9.4421 10.1128/MCB.23.22.8255-8271.2003 10.1128/JVI.02061-08 10.1126/science.3018930 10.1021/bi00137a015 10.1016/j.virol.2006.10.007 10.1016/j.chom.2009.01.009 10.1128/JVI.79.18.11952-11961.2005 10.1128/JVI.77.17.9422-9430.2003 10.1021/bi00421a001 10.1128/JVI.73.3.2126-2135.1999 10.1111/j.1432-1033.2004.04386.x 10.1002/j.1460-2075.1990.tb07516.x 10.1128/MCB.21.23.8007-8021.2001 10.1016/S0006-291X(02)02848-6 10.1074/jbc.M004670200 10.1186/1742-4690-4-45 10.1126/science.1962196 10.1128/JVI.02382-09 10.1016/j.micinf.2004.04.002 10.1016/S0014-5793(01)02945-3 10.1038/nsb0797-567 10.1128/MCB.25.16.7120-7136.2005 10.1126/science.272.5259.263 10.1038/nature10195 10.1016/S0167-4838(99)00267-8 10.1006/mthe.2000.0238 10.1016/j.chom.2008.10.004 10.1242/jcs.00613 10.1038/nm945 10.1007/978-1-4615-5373-1_2 10.1126/science.1152725 10.1128/JVI.76.9.4341-4349.2002 10.1016/S0092-8674(00)80939-3 10.1074/jbc.M109.010033 10.1021/bi00064a018 10.1021/bi00098a021 10.1128/JVI.74.10.4795-4806.2000 10.1186/1742-4690-2-62 10.1128/JVI.00519-07 10.1073/pnas.95.14.7898 10.1128/JVI.78.10.5045-5055.2004 10.1128/jvi.69.5.2729-2736.1995 10.1128/MCB.7.8.2745 10.1073/pnas.0906404106 10.1016/j.cell.2008.07.032 10.1099/vir.0.81382-0 10.1128/JVI.00676-09 10.1016/0092-8674(90)90802-L 10.1128/JVI.72.9.7648-7652.1998 10.1073/pnas.96.22.12667 10.1016/S0021-9258(19)84762-2 10.1128/JVI.78.16.8477-8485.2004 10.3390/v2010147 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2013 BioMed Central Ltd. 2013 Boso et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Copyright ©2013 Boso et al.; licensee BioMed Central Ltd. 2013 Boso et al.; licensee BioMed Central Ltd. |
Copyright_xml | – notice: COPYRIGHT 2013 BioMed Central Ltd. – notice: 2013 Boso et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. – notice: Copyright ©2013 Boso et al.; licensee BioMed Central Ltd. 2013 Boso et al.; licensee BioMed Central Ltd. |
DBID | FBQ CGR CUY CVF ECM EIF NPM AAYXX CITATION ISR 3V. 7U9 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH H94 K9. M0S M1P PIMPY PQEST PQQKQ PQUKI PRINS 5PM |
DOI | 10.1186/1743-422X-10-233 |
DatabaseName | AGRIS Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Gale In Context: Science ProQuest Central (Corporate) Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) Medical Database Publicly Available Content Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Publicly Available Content Database Virology and AIDS Abstracts ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest Medical Library ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central Korea AIDS and Cancer Research Abstracts ProQuest One Academic ProQuest Medical Library (Alumni) ProQuest Central (Alumni) |
DatabaseTitleList | MEDLINE AIDS and Cancer Research Abstracts CrossRef Publicly Available Content Database |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database – sequence: 4 dbid: FBQ name: AGRIS url: http://www.fao.org/agris/Centre.asp?Menu_1ID=DB&Menu_2ID=DB1&Language=EN&Content=http://www.fao.org/agris/search?Language=EN sourceTypes: Publisher |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Biology |
EISSN | 1743-422X |
EndPage | 233 |
ExternalDocumentID | oai_biomedcentral_com_1743_422X_10_233 3024593481 A534694357 10_1186_1743_422X_10_233 23849394 US201500218724 |
Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GeographicLocations | United States |
GeographicLocations_xml | – name: United States |
GrantInformation_xml | – fundername: NHLBI NIH HHS grantid: R01 HL083365 – fundername: NCI NIH HHS grantid: P30CA77598 – fundername: NIAID NIH HHS grantid: R21 AI087466 |
GroupedDBID | --- -A0 123 29Q 2VQ 2WC 3V. 4.4 53G 5VS 7X7 88E 8FI 8FJ AAFWJ AAJSJ ABDBF ABPTK ABUWG ABVAZ ACGFO ACGFS ACIHN ACPRK ACRMQ ADBBV ADINQ ADRAZ AEAQA AENEX AFGXO AFKRA AFNRJ AFPKN AHBYD AHMBA AHSBF AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C1A C24 C6C CCPQU CS3 DIK E3Z EAD EAP EAS EBD EBS EJD EMB EMK EMOBN ESX F5P FBQ FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IFM IGS IHR INH INR IPNFZ ISR ITC KQ8 M1P M48 M~E NXXTH O5R O5S OK1 P2P PIMPY PQQKQ PROAC PSQYO RBZ RIG RNS ROL RPM RSV SBL SOJ SV3 TR2 TUS UKHRP WOQ WOW XSB 0R~ ADUKV CGR CUY CVF ECM EIF NPM AAHBH AAYXX ACMJI ALIPV CITATION EBLON H13 PGMZT 7U9 7XB 8FK AZQEC DWQXO H94 K9. PQEST PQUKI PRINS 5PM |
ID | FETCH-LOGICAL-b642t-4b5f0f694844bfab9194117f3af2acc8c55575a379a506e66cddbe81af99fdbb3 |
IEDL.DBID | RBZ |
ISSN | 1743-422X |
IngestDate | Tue Sep 17 21:26:34 EDT 2024 Wed May 22 07:14:10 EDT 2024 Fri Aug 16 21:05:59 EDT 2024 Fri Sep 13 06:53:38 EDT 2024 Wed Aug 14 18:52:59 EDT 2024 Tue Aug 13 05:22:48 EDT 2024 Wed Sep 25 21:13:02 EDT 2024 Thu Sep 12 16:51:42 EDT 2024 Thu May 23 23:18:07 EDT 2024 Wed Dec 27 19:17:54 EST 2023 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
License | This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-b642t-4b5f0f694844bfab9194117f3af2acc8c55575a379a506e66cddbe81af99fdbb3 |
Notes | http://dx.doi.org/10.1186/1743-422X-10-233 ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 |
OpenAccessLink | http://dx.doi.org/10.1186/1743-422X-10-233 |
PMID | 23849394 |
PQID | 1406089793 |
PQPubID | 55248 |
PageCount | 1 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_3716682 biomedcentral_primary_oai_biomedcentral_com_1743_422X_10_233 proquest_miscellaneous_1419369904 proquest_journals_1406089793 gale_infotracmisc_A534694357 gale_infotracacademiconefile_A534694357 gale_incontextgauss_ISR_A534694357 crossref_primary_10_1186_1743_422X_10_233 pubmed_primary_23849394 fao_agris_US201500218724 |
PublicationCentury | 2000 |
PublicationDate | 2013-07-13 |
PublicationDateYYYYMMDD | 2013-07-13 |
PublicationDate_xml | – month: 07 year: 2013 text: 2013-07-13 day: 13 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | Virology journal |
PublicationTitleAlternate | Virol J |
PublicationYear | 2013 |
Publisher | Springer-Verlag BioMed Central Ltd BioMed Central |
Publisher_xml | – name: Springer-Verlag – name: BioMed Central Ltd – name: BioMed Central |
References | 19460752 - J Biol Chem. 2009 Jul 17;284(29):19463-73 12915557 - J Virol. 2003 Sep;77(17):9422-30 21994605 - Viruses. 2010 Jan;2(1):147-65 16603535 - J Gen Virol. 2006 May;87(Pt 5):1321-30 3670292 - Mol Cell Biol. 1987 Aug;7(8):2745-52 8384879 - Biochemistry. 1993 Apr 6;32(13):3347-53 2331748 - Cell. 1990 Apr 20;61(2):213-22 9491887 - Cell. 1998 Feb 20;92(4):451-62 7535863 - J Virol. 1995 May;69(5):2729-36 19286137 - Cell Host Microbe. 2009 Mar 19;5(3):285-97 11682056 - FEBS Lett. 2001 Oct 19;507(1):39-44 9971795 - J Virol. 1999 Mar;73(3):2126-35 15207818 - Microbes Infect. 2004 Jul;6(8):715-24 10535980 - Proc Natl Acad Sci U S A. 1999 Oct 26;96(22):12667-72 11689692 - Mol Cell Biol. 2001 Dec;21(23):8007-21 20219923 - J Virol. 2010 May;84(10):5181-90 12857789 - J Cell Sci. 2003 Aug 15;116(Pt 16):3433-42 18976975 - Cell Host Microbe. 2008 Nov 13;4(5):495-504 16140771 - J Virol. 2005 Sep;79(18):11952-61 2506181 - J Biol Chem. 1989 Oct 5;264(28):16700-12 17608937 - Retrovirology. 2007;4:45 10775618 - J Virol. 2000 May;74(10):4795-806 15634344 - FEBS J. 2005 Jan;272(1):203-16 17626089 - J Virol. 2007 Sep;81(18):10037-46 1606143 - Biochemistry. 1992 Jun 9;31(22):5193-200 16055722 - Mol Cell Biol. 2005 Aug;25(16):7120-36 19759158 - J Virol. 2009 Dec;83(23):12336-44 9653112 - Proc Natl Acad Sci U S A. 1998 Jul 7;95(14):7898-903 7983732 - J Virol. 1995 Jan;69(1):376-86 2209542 - EMBO J. 1990 Oct;9(10):3179-89 3069123 - Biochemistry. 1988 Oct 18;27(21):7979-84 15280456 - J Virol. 2004 Aug;78(16):8477-85 17109911 - Virology. 2007 Mar 30;360(1):129-35 1962196 - Science. 1991 Nov 29;254(5036):1374-7 14585983 - Mol Cell Biol. 2003 Nov;23(22):8255-71 14528300 - Nat Med. 2003 Nov;9(11):1404-7 10893419 - J Biol Chem. 2000 Sep 22;275(38):29749-53 8633082 - Proc Natl Acad Sci U S A. 1996 Apr 30;93(9):4421-4 16232319 - Retrovirology. 2005;2:62 9696869 - J Virol. 1998 Sep;72(9):7648-52 11162316 - Mol Ther. 2001 Jan;3(1):97-104 18187620 - Science. 2008 Feb 15;319(5865):921-6 11932400 - J Virol. 2002 May;76(9):4341-9 19620738 - Proc Natl Acad Sci U S A. 2009 Aug 11;106(32):13618-23 9228950 - Nat Struct Biol. 1997 Jul;4(7):567-77 15113886 - J Virol. 2004 May;78(10):5045-55 21720370 - Nature. 2011 Jun 30;474(7353):658-61 19369352 - J Virol. 2009 Jul;83(13):6522-33 12504078 - Biochem Biophys Res Commun. 2003 Jan 10;300(2):268-70 3018930 - Science. 1986 Oct 10;234(4773):179-86 1883829 - Biochemistry. 1991 Aug 27;30(34):8424-34 8602510 - Science. 1996 Apr 12;272(5259):263-7 9561194 - Adv Exp Med Biol. 1998;436:15-25 18854154 - Cell. 2008 Oct 3;135(1):49-60 10708846 - Biochim Biophys Acta. 2000 Mar 7;1477(1-2):16-34 SK Fodor (2211_CR33) 2002; 76 JW Tobias (2211_CR15) 1991; 254 T Tasara (2211_CR42) 2001; 507 C Chen (2211_CR56) 1987; 7 A Bachmair (2211_CR12) 1986; 234 YT Kwon (2211_CR50) 2003; 23 ML Yeung (2211_CR8) 2009; 284 M Wiskerchen (2211_CR25) 1995; 69 RA Fridell (2211_CR4) 1996; 93 A Feher (2211_CR26) 2006; 87 N Tsurutani (2211_CR41) 2000; 74 J Tozser (2211_CR30) 1993; 32 JT Griffiths (2211_CR29) 1992; 31 J Snasel (2211_CR35) 2005; 272 AL Brass (2211_CR6) 2008; 319 J Tozser (2211_CR22) 2010; 2 X Wu (2211_CR40) 1999; 73 P Wei (2211_CR3) 1998; 92 KI Pfrepper (2211_CR31) 1998; 72 CL Woodward (2211_CR39) 2009; 83 YT Kwon (2211_CR49) 2001; 21 C Goffinet (2211_CR10) 2009; 5 A Wlodawer (2211_CR32) 2000; 1477 SC Pettit (2211_CR27) 1998; 436 M Cai (2211_CR48) 1997; 4 H Zhou (2211_CR5) 2008; 4 CW Dobard (2211_CR44) 2007; 81 DK Gonda (2211_CR13) 1989; 264 T de Oliveira (2211_CR23) 2003; 77 LL Dunn (2211_CR46) 2009; 83 AG Lloyd (2211_CR21) 2007; 360 NV Somia (2211_CR55) 1999; 96 Z Ao (2211_CR38) 2005; 2 B Bartel (2211_CR16) 1990; 9 K Zhu (2211_CR43) 2004; 78 H Ebina (2211_CR2) 2004; 6 SC Pettit (2211_CR36) 2004; 78 JA Zack (2211_CR57) 1990; 61 YT Kwon (2211_CR17) 1998; 95 LC Mulder (2211_CR20) 2000; 275 L Naldini (2211_CR54) 1996; 272 SK Grant (2211_CR28) 1991; 30 C Petit (2211_CR1) 2003; 116 T Tasaki (2211_CR18) 2005; 25 AM Sheehy (2211_CR9) 2003; 9 ME Abram (2211_CR45) 2005; 79 A Engelman (2211_CR24) 1995; 69 R Konig (2211_CR7) 2008; 135 SM Arfin (2211_CR19) 1988; 27 P Lech (2211_CR52) 2007; 4 K Xu (2211_CR53) 2001; 3 K Hrecka (2211_CR11) 2011; 474 J Karn (2211_CR47) 1995 E Graciet (2211_CR14) 2009; 106 MS Briones (2211_CR37) 2010; 84 VL Mariani (2211_CR34) 2003; 300 E Harlow (2211_CR51) 1988 |
References_xml | – volume: 69 start-page: 376 year: 1995 ident: 2211_CR25 publication-title: J Virol doi: 10.1128/jvi.69.1.376-386.1995 contributor: fullname: M Wiskerchen – volume: 93 start-page: 4421 year: 1996 ident: 2211_CR4 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.93.9.4421 contributor: fullname: RA Fridell – volume: 23 start-page: 8255 year: 2003 ident: 2211_CR50 publication-title: Mol Cell Biol doi: 10.1128/MCB.23.22.8255-8271.2003 contributor: fullname: YT Kwon – volume: 83 start-page: 6522 year: 2009 ident: 2211_CR39 publication-title: J Virol doi: 10.1128/JVI.02061-08 contributor: fullname: CL Woodward – volume: 234 start-page: 179 year: 1986 ident: 2211_CR12 publication-title: Science doi: 10.1126/science.3018930 contributor: fullname: A Bachmair – volume: 31 start-page: 5193 year: 1992 ident: 2211_CR29 publication-title: Biochemistry doi: 10.1021/bi00137a015 contributor: fullname: JT Griffiths – volume: 360 start-page: 129 year: 2007 ident: 2211_CR21 publication-title: Virology doi: 10.1016/j.virol.2006.10.007 contributor: fullname: AG Lloyd – volume: 5 start-page: 285 year: 2009 ident: 2211_CR10 publication-title: Cell Host Microbe doi: 10.1016/j.chom.2009.01.009 contributor: fullname: C Goffinet – volume: 79 start-page: 11952 year: 2005 ident: 2211_CR45 publication-title: J Virol doi: 10.1128/JVI.79.18.11952-11961.2005 contributor: fullname: ME Abram – volume: 77 start-page: 9422 year: 2003 ident: 2211_CR23 publication-title: J Virol doi: 10.1128/JVI.77.17.9422-9430.2003 contributor: fullname: T de Oliveira – volume: 27 start-page: 7979 year: 1988 ident: 2211_CR19 publication-title: Biochemistry doi: 10.1021/bi00421a001 contributor: fullname: SM Arfin – volume: 73 start-page: 2126 year: 1999 ident: 2211_CR40 publication-title: J Virol doi: 10.1128/JVI.73.3.2126-2135.1999 contributor: fullname: X Wu – volume: 272 start-page: 203 year: 2005 ident: 2211_CR35 publication-title: FEBS J doi: 10.1111/j.1432-1033.2004.04386.x contributor: fullname: J Snasel – volume: 9 start-page: 3179 year: 1990 ident: 2211_CR16 publication-title: EMBO J doi: 10.1002/j.1460-2075.1990.tb07516.x contributor: fullname: B Bartel – volume: 21 start-page: 8007 year: 2001 ident: 2211_CR49 publication-title: Mol Cell Biol doi: 10.1128/MCB.21.23.8007-8021.2001 contributor: fullname: YT Kwon – volume: 300 start-page: 268 year: 2003 ident: 2211_CR34 publication-title: Biochem Biophys Res Commun doi: 10.1016/S0006-291X(02)02848-6 contributor: fullname: VL Mariani – volume: 275 start-page: 29749 year: 2000 ident: 2211_CR20 publication-title: J Biol Chem doi: 10.1074/jbc.M004670200 contributor: fullname: LC Mulder – volume: 4 start-page: 45 year: 2007 ident: 2211_CR52 publication-title: Retrovirology doi: 10.1186/1742-4690-4-45 contributor: fullname: P Lech – volume: 254 start-page: 1374 year: 1991 ident: 2211_CR15 publication-title: Science doi: 10.1126/science.1962196 contributor: fullname: JW Tobias – volume: 84 start-page: 5181 year: 2010 ident: 2211_CR37 publication-title: J Virol doi: 10.1128/JVI.02382-09 contributor: fullname: MS Briones – volume: 6 start-page: 715 year: 2004 ident: 2211_CR2 publication-title: Microbes Infect doi: 10.1016/j.micinf.2004.04.002 contributor: fullname: H Ebina – volume: 507 start-page: 39 year: 2001 ident: 2211_CR42 publication-title: FEBS Lett doi: 10.1016/S0014-5793(01)02945-3 contributor: fullname: T Tasara – volume: 4 start-page: 567 year: 1997 ident: 2211_CR48 publication-title: Nat Struct Biol doi: 10.1038/nsb0797-567 contributor: fullname: M Cai – volume: 25 start-page: 7120 year: 2005 ident: 2211_CR18 publication-title: Mol Cell Biol doi: 10.1128/MCB.25.16.7120-7136.2005 contributor: fullname: T Tasaki – volume: 272 start-page: 263 year: 1996 ident: 2211_CR54 publication-title: Science doi: 10.1126/science.272.5259.263 contributor: fullname: L Naldini – volume: 474 start-page: 658 year: 2011 ident: 2211_CR11 publication-title: Nature doi: 10.1038/nature10195 contributor: fullname: K Hrecka – volume: 1477 start-page: 16 year: 2000 ident: 2211_CR32 publication-title: Biochim Biophys Acta doi: 10.1016/S0167-4838(99)00267-8 contributor: fullname: A Wlodawer – volume: 3 start-page: 97 year: 2001 ident: 2211_CR53 publication-title: Mol Ther doi: 10.1006/mthe.2000.0238 contributor: fullname: K Xu – volume: 4 start-page: 495 year: 2008 ident: 2211_CR5 publication-title: Cell Host Microbe doi: 10.1016/j.chom.2008.10.004 contributor: fullname: H Zhou – volume: 116 start-page: 3433 year: 2003 ident: 2211_CR1 publication-title: J Cell Sci doi: 10.1242/jcs.00613 contributor: fullname: C Petit – volume: 9 start-page: 1404 year: 2003 ident: 2211_CR9 publication-title: Nat Med doi: 10.1038/nm945 contributor: fullname: AM Sheehy – volume: 436 start-page: 15 year: 1998 ident: 2211_CR27 publication-title: Adv Exp Med Biol doi: 10.1007/978-1-4615-5373-1_2 contributor: fullname: SC Pettit – volume: 319 start-page: 921 year: 2008 ident: 2211_CR6 publication-title: Science doi: 10.1126/science.1152725 contributor: fullname: AL Brass – volume: 76 start-page: 4341 year: 2002 ident: 2211_CR33 publication-title: J Virol doi: 10.1128/JVI.76.9.4341-4349.2002 contributor: fullname: SK Fodor – volume: 92 start-page: 451 year: 1998 ident: 2211_CR3 publication-title: Cell doi: 10.1016/S0092-8674(00)80939-3 contributor: fullname: P Wei – volume: 284 start-page: 19463 year: 2009 ident: 2211_CR8 publication-title: J Biol Chem doi: 10.1074/jbc.M109.010033 contributor: fullname: ML Yeung – volume: 32 start-page: 3347 year: 1993 ident: 2211_CR30 publication-title: Biochemistry doi: 10.1021/bi00064a018 contributor: fullname: J Tozser – volume: 30 start-page: 8424 year: 1991 ident: 2211_CR28 publication-title: Biochemistry doi: 10.1021/bi00098a021 contributor: fullname: SK Grant – volume: 74 start-page: 4795 year: 2000 ident: 2211_CR41 publication-title: J Virol doi: 10.1128/JVI.74.10.4795-4806.2000 contributor: fullname: N Tsurutani – volume: 2 start-page: 62 year: 2005 ident: 2211_CR38 publication-title: Retrovirology doi: 10.1186/1742-4690-2-62 contributor: fullname: Z Ao – volume: 81 start-page: 10037 year: 2007 ident: 2211_CR44 publication-title: J Virol doi: 10.1128/JVI.00519-07 contributor: fullname: CW Dobard – volume-title: Antibodies: a laboratory manual year: 1988 ident: 2211_CR51 contributor: fullname: E Harlow – volume: 95 start-page: 7898 year: 1998 ident: 2211_CR17 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.95.14.7898 contributor: fullname: YT Kwon – volume: 78 start-page: 5045 year: 2004 ident: 2211_CR43 publication-title: J Virol doi: 10.1128/JVI.78.10.5045-5055.2004 contributor: fullname: K Zhu – volume: 69 start-page: 2729 year: 1995 ident: 2211_CR24 publication-title: J Virol doi: 10.1128/jvi.69.5.2729-2736.1995 contributor: fullname: A Engelman – volume: 7 start-page: 2745 year: 1987 ident: 2211_CR56 publication-title: Mol Cell Biol doi: 10.1128/MCB.7.8.2745 contributor: fullname: C Chen – volume: 106 start-page: 13618 year: 2009 ident: 2211_CR14 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.0906404106 contributor: fullname: E Graciet – volume-title: HIV : a practical approach year: 1995 ident: 2211_CR47 contributor: fullname: J Karn – volume: 135 start-page: 49 year: 2008 ident: 2211_CR7 publication-title: Cell doi: 10.1016/j.cell.2008.07.032 contributor: fullname: R Konig – volume: 87 start-page: 1321 year: 2006 ident: 2211_CR26 publication-title: J Gen Virol doi: 10.1099/vir.0.81382-0 contributor: fullname: A Feher – volume: 83 start-page: 12336 year: 2009 ident: 2211_CR46 publication-title: J Virol doi: 10.1128/JVI.00676-09 contributor: fullname: LL Dunn – volume: 61 start-page: 213 year: 1990 ident: 2211_CR57 publication-title: Cell doi: 10.1016/0092-8674(90)90802-L contributor: fullname: JA Zack – volume: 72 start-page: 7648 year: 1998 ident: 2211_CR31 publication-title: J Virol doi: 10.1128/JVI.72.9.7648-7652.1998 contributor: fullname: KI Pfrepper – volume: 96 start-page: 12667 year: 1999 ident: 2211_CR55 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.96.22.12667 contributor: fullname: NV Somia – volume: 264 start-page: 16700 year: 1989 ident: 2211_CR13 publication-title: J Biol Chem doi: 10.1016/S0021-9258(19)84762-2 contributor: fullname: DK Gonda – volume: 78 start-page: 8477 year: 2004 ident: 2211_CR36 publication-title: J Virol doi: 10.1128/JVI.78.16.8477-8485.2004 contributor: fullname: SC Pettit – volume: 2 start-page: 147 year: 2010 ident: 2211_CR22 publication-title: Viruses doi: 10.3390/v2010147 contributor: fullname: J Tozser |
SSID | ssj0032679 |
Score | 2.0534098 |
Snippet | BACKGROUND: Integration of double stranded viral DNA is a key step in the retroviral life cycle. Virally encoded enzyme, integrase, plays a central role in... Integration of double stranded viral DNA is a key step in the retroviral life cycle. Virally encoded enzyme, integrase, plays a central role in this reaction.... Abstract Background Integration of double stranded viral DNA is a key step in the retroviral life cycle. Virally encoded enzyme, integrase, plays a central... Background Integration of double stranded viral DNA is a key step in the retroviral life cycle. Virally encoded enzyme, integrase, plays a central role in this... Doc number: 233 Abstract Background: Integration of double stranded viral DNA is a key step in the retroviral life cycle. Virally encoded enzyme, integrase,... Background: Integration of double stranded viral DNA is a key step in the retroviral life cycle. Virally encoded enzyme, integrase, plays a central role in... |
SourceID | pubmedcentral biomedcentral proquest gale crossref pubmed fao |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 233 |
SubjectTerms | amino acids Animals Cancer Cell Line DNA Enzymes fibroblasts Genetic aspects Genomes half life HIV Integrase - genetics HIV Integrase - metabolism HIV-1 - physiology Human immunodeficiency virus 1 Humans Mammals Mice Microtubule-Associated Proteins - metabolism Mutant Proteins - genetics Mutant Proteins - metabolism mutants pathogenicity Physiological aspects Proteins proteolysis quantitative polymerase chain reaction Retrovirus Retrovirus infections Reverse Transcription Risk factors Sequence Deletion Ubiquitin ubiquitin-protein ligase Ubiquitin-Protein Ligases - metabolism Viral infections Virus Integration |
SummonAdditionalLinks | – databaseName: PubMed Central dbid: RPM link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR1daxQxMPQKii-i9aOrVVYRxIf0dvO5EUFKsVThilgP7i0k2aQtXLOld_fgv3eyH0dXffJtYSYhm_lOJjMIvTPUkdpxgn3tOWahothyHrC3TErhmfA8vXeenYnTOfu24IsdxIe3MG3SvrNXh3F5fRivLtvcyptrNx3yxKbfZ8cUnHxRkekETSSlQ4jeqV9wR6Qa7iMrMU0eN2aELJLCITT1zQErxRRVf75xX45M0ySY5m81fcdOjXMo7xilk0foYe9N5kfdqh-jHR_30L2uv-SvPXR_1t-cP0GfgR_yM-xjnd9ulj436cOv04ECzJsPOVnxYx6bvEvyyJuY99UkVv4pmp98-Xl8ivvmCdhCSLHGzPJQBKFYxZgNxqpSsbKUgZpAjHOV4xw8NUOlMrwQXghX19ZXpQlKhdpa-gztxib6fZTTWhQ-1K52RjLhlOIwIakgMOSVoVZm6NNoH_VNVyhDp9LVYwhIkU4U0YkiGgIQoEiGPgzbvh3ZhiaV-AfuPtBFmwvQgHp-TtJ5TfJSJGEZepuIpVNRi5iyZi7MZrXSX89_6CNOGewE5bDU9z1SaGBBzvSPEOBHUx2sEebBCBOkzo3BA0_oXupXEEYVoqgUqLwMvdmC08iUyRZ9s0k4ZeqhqApY8POOhbZ_PTBmhuSIuUYbOoaAiLQ1wXuRePHfI1-iB6Tt9CFxSQ_Q7vp241-Bv7W2r1v5-g2vOShs priority: 500 providerName: National Library of Medicine – databaseName: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1daxQxMPQDxRfR-tGrVVYRxIdwt_najQilSssp9JDWg3sLSTapQtlte3cP_ntn9uNsUHxbdiYhyUwmM5PJDCFvLfes8pLRUAVJRSw5dVJGGpwoChWEChLfO5_N1HQuvi7kYotMh7cwGFY5yMRWUFeNRx_5GAwBNSk1sNPYOvQC-NX46PqGYv0ovGfti2lsk12WC7yw3f10Mvt2Pkhl0FLavHuogFPB2GK4sizVePMPZRLDErrJ2_er5Mjajrb5W3zfOb_S2Mo7h9XpI_Kw1zKz444tHpOtUO-Re13dyV975P5Zf6P-hBwBn2QzGuoqu11fhcziR1ihowH6zYZYrfpDVjdZF_yRNXXWZ5lYhqdkfnry_fOU9kUVqANTY0WFk3ESlRalEC5ap3Mt8ryI3EZmvS-9lKDBWV5oKycqKOWryoUyt1HrWDnHn5GduqnDPsl4pSYhVr7ythDKay2hQ1aCwShLy10xIh-TdTTXXQINgymtUwhQ2iAZDJLBgGECZBiR98Oyb1q2Jkup_oG7D3Qx9hIko5lfMPTjoPZSMDEib5BYBpNd1BhNc2nXy6X5cnFujiUXsBJcwlDf9UixQd6y_eMEmCjmx0owDxNM2I0-BQ88YXppsDR_eHdEXm_A2BIj3OrQrBEnx9qKegIDft6x0GbWoFYJzTVAioS5kgVNIfXPH22ucA72sCrZwf-H9YI8YG2Zj4Lm_JDsrG7X4SUoWyv3qt9HvwE4aiaM priority: 102 providerName: ProQuest – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3daxQxEA-2ovRFtH50tcoqgviwupuvTUQpRSxVuD5YD-4tJNmkCsduvQ-w_70z-3F29XxbyCRkZ36TzCSTGUJeWuZp5QXNQhVExqNimRMiZsHxspSByyDwvfPkTJ5O-ZeZmP15Ht0zcLnVtcN6UtPF_M2vn1dHoPAfWoVX8i0a1RmndIZrCmVsh9yknHHE-4Rv7hTATin1cFG5pRemBWaKa6b_fvw-H-1ZO9E2_67f1zawcXDltd3q5C6505uZ6XGHi3vkRqj3ya2u8OTVPrk96a_U75MjAEp6loW6ShfreUgtfoQVnjTAuOkQrFW_S-sm7aI_0qZO-zQTy_CATE8-fft4mvVVFTIHvsYq407EPErNFecuWqcLzYuijMxGar1XXggw4SwrtRW5DFL6qnJBFTZqHSvn2EOyWzd1OCApq2QeYuUrb0suvdYCBqQKPEahLHNlQt6P-GguuwwaBnNaj1tAvQxKxKBEDHgmIJGEvB7YvunZ-ixKbqE9ALkYewFLo5meUzzIQfOlpDwhL1BYBrNd1BhOc2HXy6X5fP7VHAuAiQaLEab6qieKDUzI2_51AvwoJsgaUR6OKEEd_bh5wIQZ0Az-VS5zpWEtTMjzTTP2xBC3OjRrpCmwuKLOYcKPOght_noAZkLKEbhGDB231D--t8nCGTjEUtHH_x3zCdmjbYmPMivYIdldLdbhKRhaK_es1Z_f1xsh9w priority: 102 providerName: Scholars Portal |
Title | N-end rule and retroviral infection: no effect on integrase |
URI | https://www.ncbi.nlm.nih.gov/pubmed/23849394 https://www.proquest.com/docview/1406089793/abstract/ https://search.proquest.com/docview/1419369904 http://dx.doi.org/10.1186/1743-422X-10-233 https://pubmed.ncbi.nlm.nih.gov/PMC3716682 |
Volume | 10 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3daxQxEA9ei-KLaP3oaV1WEcSHxd18RwS5Sks9uEN6Hhy-hCSbVKHsSu_uwf_eyX6c3do3X3YXZjYkmWQyM5n8gtAbQxwuHcOZLz3LaJAks4yFzFsqBPeUexbPO8_m_GxJpyu2-guTc2MHv5D8fTSZM4rxKmoMTMgI7eMIch498-PvvdYFK6TB1dtx91uSt5Rw42z75WBJGgVT_6uer61Pw9zJa4vR6UP0oLMi00kr9kfojq8O0N32XsnfB-jerNsxf4w-wThI55mvyvRqe-lTEz_8JgYSoNy0z8WqPqRVnbbJHWldpR2KxNo_QcvTk2-fz7Lu0oTMgiuxyahlIQ9cUUmpDcaqQtGiEIGYgI1z0jEGFpohQhmWc8-5K0vrZWGCUqG0ljxFe1Vd-UOUkpLnPpSudEZQ7pRiUCCW4BAyaYgVY_Rx0I_6VwuQoSNk9ZACs0dHMegoBg2OB4hhjN713b77s3FJJL-F9xDkos0FaD69XOAYp4nWicB0jF5HYekIZlHFbJkLs12v9ZfFuZ4wAt4_GIRQ1bcdU6ihQs50hw-goRH_asB5NOCE2eaG5H5M6G62r8F9ynkuFai6MXq1I8c_YwZb5ett5Cni3Ykqhwo_a4fQrtVgNlFFFFDEYHANOnRIqX7-aLDACfi7XOLn_yeKF-g-bq75EFlBjtDe5mrrX4KxtbEJGomVSND-ZDJdTOF9fDL_ep40oQt4zqhMmnmYNHGyP26LKbM |
link.rule.ids | 108,230,315,733,786,790,870,891,2236,12083,21416,24346,24965,27957,27958,31754,31755,33779,33780,43345,43840,53827,53829,76169,76170 |
linkProvider | BioMedCentral |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1daxQxMNiKHy-i1drTqqsI4kPobb52I0IpYrlq7x5sD-4tJNmkCmW39u4e_PfO7MfZoPi27ExCkplMZiaTGULeWu5Z5SWjoQqSilhy6qSMNDhRFCoIFSS-d57O1GQuvizkone4LfuwykEmtoK6ajz6yA_AEFDjUgM7HV79pFg1Cm9X-xIaW-S24FxgSF-x2BhcoJm0ufZQ6aaCscVwTVmqg80_lEMMy-Ym790vk2NqK9rmb5F948xK4ylvHFDHD8mDXrPMjjpWeERuhXqH3OlqTf7aIXen_S36Y3IIvJHNaKir7Hp9GTKLH2GFzgXoNxvis-oPWd1kXcBH1tRZn1liGZ6Q-fHn808T2hdSoA7MixUVTsZxVFqUQrhonc61yPMichuZ9b70UoLWZnmhrRyroJSvKhfK3EatY-Uc3yXbdVOHPZLxSo1DrHzlbSGU11pCh6wEI1GWlrtiRD4m62iuuqQZBtNYpxCgrkEyGCSDAWMEyDAi74dl37RszZRS_QN3D-hi7AVIQzM_Y-i7QY2lYGJE3iCxDCa4qDGC5sKul0tzcvbNHEkuYCW4hKG-65FiAwPytn-QABPFnFgJ5n6CCTvQp-CBJ0wvAZbmD7-OyOsNGFtiVFsdmjXi5FhPUY9hwE87FtrMGlQpobkGSJEwV7KgKaT-8b3ND87BBlYle_b_Yb0i9ybn01NzejL7-pzcZ22Zj4LmfJ9sr67X4QUoWyv3st1RvwEuDSRZ |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpR1daxQxMNiKxRfR-tHTqqsI4sO2u_najQhSP45W7SGtB4cvIckmtfTYLb27B_-9M7t7x0X75ltgJiGZmUxmkpkJIa8Mc7Rygqa-8iLloWSpFSKk3vKikJ5LLzDf-XgkD8f8y0RM-vRozIXB5C68Tu4pubeehD5tNTc03MX-ZRW6DV_KfTSqU07pBHUKZWyD3ATnXKKMn3z4udTLYKe0lfdW2MtHy2tG-Cv7fRodWhvBNP8q8LUTLI6uXDuuhnfJnd7OTA46wbhHbvh6m9zqfp78vU22jvs39fvkPUhKMkp9XSVXi6lPDDb8HK8aYNxkGa1Vv03qJunCP5KmTvo6EzP_gIyHn398PEz7bxVSC87GPOVWhCxIxUvObTBW5YrneRGYCdQ4VzohwIYzrFBGZNJL6arK-jI3QalQWcseks26qf0OSVglMx8qVzlTcOmUEjAgLcFlFKVhthiQdxEd9WVXQkNjUesYAqzVyAaNbNDgmgAbBuTNkuyrnq3TUsprcHeAL9qcgW7U41OKNzlovxSUD8hLZJbGchc1xtOcmcVspo9OT_SBYBwowQRM9XWPFBoUMdOnJ8BCsUJWhLkbYcJ-dDF4KRO6l-IZOFiZzEoFynBAXqzA2BNj3GrfLBAnx98VVQYTftSJ0GrVYFhxxRRAiki4IoLGkPr8V1stnIFHLEv6-P9Y8Zxsff801N-ORl-fkNu0_ROkSHO2SzbnVwv_FCyzuX3Wbrg_zjAzSA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+N-end+rule+and+retroviral+infection%3A+no+effect+on+integrase&rft.jtitle=Virology+journal&rft.au=Boso%2C+Guney&rft.au=Tasaki%2C+Takafumi&rft.au=Kwon%2C+Yong+Tae&rft.au=Somia%2C+Nikunj+V&rft.date=2013-07-13&rft.eissn=1743-422X&rft.volume=10&rft.spage=233&rft_id=info:doi/10.1186%2F1743-422X-10-233&rft_id=info%3Apmid%2F23849394&rft.externalDocID=23849394 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1743-422X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1743-422X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1743-422X&client=summon |